These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29937447)

  • 21. Overexpression of 27-kDa heat shock protein relates to poor histological differentiation in human oesophageal squamous cell carcinoma.
    Lambot MA; Peny MO; Fayt I; Haot J; Noël JC
    Histopathology; 2000 Apr; 36(4):326-30. PubMed ID: 10759946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of phosphatase regenerating liver 3 in oesophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1.
    Lou X; Liu Y; Lei JY; Li H
    Cell Biol Int; 2012 Aug; 36(8):759-63. PubMed ID: 22551255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
    Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?
    Boone J; Ten Kate FJ; Offerhaus GJ; van Diest PJ; Rinkes IH; van Hillegersberg R
    J Clin Pathol; 2008 Aug; 61(8):909-13. PubMed ID: 18474542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features.
    Li AF; Li AC; Hsu CY; Li WY; Hsu HS; Chen JY
    J Clin Pathol; 2010 Jul; 63(7):620-5. PubMed ID: 20530158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
    Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and prognostic relevance of p21WAF1 in stage III esophageal squamous cell carcinoma.
    Liu J; Hu Y; Hu W; Xie X; Ela Bella A; Fu J; Rao D
    Dis Esophagus; 2012 Jan; 25(1):67-71. PubMed ID: 21689205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus.
    Khan AN; Yang W; Seifalian AM; Winslet MC
    Br J Cancer; 2006 Apr; 94(8):1213-4; author reply 1214-5. PubMed ID: 16622443
    [No Abstract]   [Full Text] [Related]  

  • 30. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness?
    Lam KY; Law S; Ma LT; Ong SK; Wong J
    Eur J Cancer; 1997 Jul; 33(8):1221-5. PubMed ID: 9301446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical relevance of Fas expression in oesophageal squamous cell carcinoma.
    Chan KW; Lee PY; Lam AK; Law S; Wong J; Srivastava G
    J Clin Pathol; 2006 Jan; 59(1):101-4. PubMed ID: 16394289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.
    Lim SH; Hong M; Ahn S; Choi YL; Kim KM; Oh D; Ahn YC; Jung SH; Ahn MJ; Park K; Zo JI; Shim YM; Sun JM
    Eur J Cancer; 2016 Jan; 52():1-9. PubMed ID: 26623522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
    Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
    Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma.
    Ohira M; Kubo N; Masuda G; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):4897-901. PubMed ID: 26254385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K; Watanabe S
    Dis Esophagus; 1998 Jan; 11(1):35-9. PubMed ID: 9595230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma.
    Tachibana M; Shibakita M; Ohno S; Kinugasa S; Yoshimura H; Ueda S; Fujii T; Rahman MA; Dhar DK; Nagasue N
    Cancer; 2002 Apr; 94(7):1955-60. PubMed ID: 11932897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression analysis of BRUCE protein in esophageal squamous cell carcinoma.
    Salehi S; Jafarian AH; Forghanifard MM
    Ann Diagn Pathol; 2016 Oct; 24():47-51. PubMed ID: 27649954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma.
    Kim SH; Chau GC; Jang YH; Lee SI; Pyo S; Um SH
    Hum Pathol; 2013 Feb; 44(2):226-36. PubMed ID: 22944293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.